zoledronic acid has been researched along with Small Cell Lung Carcinoma in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, S; Fukuda, K; Hara, E; Kita, K; Nanjo, S; Nishihara, H; Takeuchi, S; Uehara, H; Yamada, T; Yano, S | 1 |
| Epperla, N; Pathak, R | 1 |
| Hanibuchi, M; Ikuta, K; Kakiuchi, S; Muguruma, H; Nishioka, Y; Ogino, H; Sone, S; Uehara, H; Yamada, T; Yano, S | 1 |
| Daphnis, E; Georgoulias, V; Giannakakis, K; Kokologiannakis, G; Kroustalakis, N; Liotsi, C; Lioudaki, E; Papadimitraki, E; Stylianou, K | 1 |
| Balakumaran, A; Ciuleanu, TE; García-Sáenz, JA; Henry, DH; Hirsh, V; Jacobs, I; Kanarev, V; Krzakowski, M; Lipton, L; Manegold, C; Mehta, ND; Pereira, JR; Prabhash, K; Rodriguez, G; Scagliotti, GV; Siena, S; Solal-Celigny, P; Wang, H; Woll, PJ | 1 |
1 trial(s) available for zoledronic acid and Small Cell Lung Carcinoma
| Article | Year |
|---|---|
Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: subgroup analysis from a randomized phase 3 study.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Denosumab; Diphosphonates; Double-Blind Method; Female; Follow-Up Studies; Humans; Imidazoles; International Agencies; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prognosis; RANK Ligand; Small Cell Lung Carcinoma; Survival Rate; Young Adult; Zoledronic Acid | 2012 |
4 other study(ies) available for zoledronic acid and Small Cell Lung Carcinoma
| Article | Year |
|---|---|
Organ-specific efficacy of HSP90 inhibitor in multiple-organ metastasis model of chemorefractory small cell lung cancer.
Topics: Animals; Benzoquinones; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Diphosphonates; HSP90 Heat-Shock Proteins; Humans; Imidazoles; Lactams, Macrocyclic; Liver Neoplasms; Lung Neoplasms; Male; Mice; Organ Specificity; Proto-Oncogene Mas; Proto-Oncogene Proteins c-raf; Small Cell Lung Carcinoma; Zoledronic Acid | 2016 |
Hypocalcemia Secondary to Zoledronate Therapy in a Patient With Low Vitamin D Level.
Topics: Bone Density Conservation Agents; Calcium; Diphosphonates; Humans; Hypocalcemia; Hypoparathyroidism; Imidazoles; Lung Neoplasms; Male; Middle Aged; Risk Factors; Small Cell Lung Carcinoma; Vitamin D Deficiency; Zoledronic Acid | 2015 |
Intensification therapy with anti-parathyroid hormone-related protein antibody plus zoledronic acid for bone metastases of small cell lung cancer cells in severe combined immunodeficient mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Diphosphonates; Humans; Imidazoles; Immunohistochemistry; Immunotherapy; Lung Neoplasms; Male; Mice; Mice, SCID; Parathyroid Hormone-Related Protein; Radiography; Small Cell Lung Carcinoma; Xenograft Model Antitumor Assays; Zoledronic Acid | 2009 |
Crescentic glomerulonephritis associated with vascular endothelial growth factor (VEGF) inhibitor and bisphosphonate administration.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Bone Density Conservation Agents; Diphosphonates; Drug Therapy, Combination; Glomerulonephritis; Humans; Imidazoles; Lung Neoplasms; Male; Renal Dialysis; Small Cell Lung Carcinoma; Treatment Outcome; Vascular Endothelial Growth Factor A; Zoledronic Acid | 2011 |